Collar Capital Management
PFE icon

Collar Capital Management’s Pfizer PFE Stock Holding History

Collar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.23M Buy
43,283
+810
+2% +$21.5K 0.74% 49
2026
Q2 		$1.02M Buy
42,473
+1,427
+3% +$37.3K 0.6% 54
2026
Q1 		$1.15M Buy
41,046
+811
+2% +$21.6K 0.75% 50
2025
Q4 		$1M Buy
40,235
+1,470
+4% +$37.1K 0.67% 52
2025
Q3 		$988K Buy
38,765
+3,825
+11% +$94.4K 0.69% 50
2025
Q2 		$847K Sell
34,940
-1,510
-4% -$35.2K 0.71% 47
2025
Q1 		$924K Buy
36,450
+8,135
+29% +$213K 0.84% 49
2024
Q4 		$751K Buy
+28,315
New +$768K 0.63% 52

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Collar Capital Management's PFE Position: Q3 2026 in Review

Collar Capital Management increased its Pfizer (PFE) stake by 1.9% in Q3 2026, buying an estimated $21.5K and bringing the position to 43,283 shares worth $1.23M. The position accounts for 0.74% of the portfolio, ranked #49.

Collar Capital Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Collar Capital Management held 43,283 shares of Pfizer worth $1.23M as of Q3 2026.
  • Collar Capital Management bought 810 Pfizer shares in Q3 2026, an estimated $21.5K.
  • Pfizer made up 0.74% of Collar Capital Management's portfolio in Q3 2026, its #49 holding.
  • Collar Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Collar Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.